General Information of the Compound
Compound ID
CP0401628
Compound Name
2-[4-(2-Ethoxy-phenyl)-piperazin-1-ylmethyl]-1H-benzoimidazole
    Show/Hide
Structure
Formula
C20H24N4O
Molecular Weight
336.439
Canonical SMILES
CCOc1ccccc1N1CCN(Cc2nc3ccccc3[nH]2)CC1
    Show/Hide
InChI
InChI=1S/C20H24N4O/c1-2-25-19-10-6-5-9-18(19)24-13-11-23(12-14-24)15-20-21-16-7-3-4-8-17(16)22-20/h3-10H,2,11-15H2,1H3,(H,21,22)
    Show/Hide
InChIKey
STLDHJMNWBEBGX-UHFFFAOYSA-N
Physicochemical Property
logP
3.2838
Rotatable Bonds
5
Heavy Atom Count
25
Polar Areas
44.39
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
4
Complexity
25

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 9945714
SID: 14920171
ChEMBL ID
CHEMBL127752
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01161, D(4) dopamine receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
EC50 = 25 nM
   TI
   LI
   LO
   TS